Empleados: 11 (2023.0)Categoría jurídica: 5485Tamaño: PMEFecha de creación: 2017-01-31 (9 años)Estado: ActivaSector de actividad: Commerce de détail de produits pharmaceutiques en magasin spécialiséUbicación: ESPALION (12500), Aveyron
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE MARTY : revenue, balance sheet and financial ratios
PHARMACIE MARTY is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ESPALION (12500),
this company of category PME
shows in 2025 a net income positive of 166 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
In 2025, PHARMACIE MARTY generates positive net income of 166 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 130 k€ -> 166 k€.
Resultado neto (2025)
?
Resultado neto
Definición
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Fórmula
Resultado corriente + Resultado excepcional - Impuesto sobre beneficios
165 680 €
Chargement du compte de résultat...
Cuenta de resultados
Poste
Importe
% CA
Evolución
Le compte de résultat détaillé n'est pas disponible pour cette entreprise (liasse simplifiée ou données confidentielles).
Évolution graphique
Mostrar :
Visualización creada con numbers.finance Sources : INPI & BCE - Ajustes : Ministère de l'Économie
Activo
Chargement des données...
Poste
Bruto
Amort.
Neto
%
Evolución
Données de bilan actif non disponibles pour cette entreprise
Pasivo
Chargement des données...
Poste
Ejercicio
%
Evolución
Données de bilan passif non disponibles pour cette entreprise
Ratios de solvencia y endeudamiento
The debt ratio (= Financial debt / Equity x 100) stands at 218%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 25%. The balance between equity and debt is satisfactory.
Ratio de endeudamiento (2025)
?
Ratio de endeudamiento
Definición
Mide la proporción de deuda respecto a los fondos propios.
Fórmula
(Deuda financiera / Fondos propios) x 100
Interpretación
< 50% : Faible 50-100% : Moderado > 100% : Alto
218.446%
Autonomía financiera (2025)
?
Autonomía financiera
Definición
Porcentaje de fondos propios en la financiación total.
Evolución de indicadores de solvencia PHARMACIE MARTY
Visualización creada con numbers.finance Sources : INPI & BCE - Ajustes : Ministère de l'Économie
Indicador
2018
2019
2020
2021
2022
2023
2024
2025
Ratio de endeudamiento
551.156
392.518
274.169
268.721
143.301
142.941
140.319
218.446
Autonomía financiera
13.31
17.933
23.221
22.13
33.387
32.726
35.146
25.425
Capacidad de reembolso
None
None
None
None
None
None
None
None
Flujo de caja / Ingresos
None%
None%
None%
None%
None%
None%
None%
None%
Positionnement sectoriel
Debt ratio
218.452025
2023
2024
2025
Q1: 13.57
Méd: 49.47
Q3: 128.28
Average+6 pts durante 3 años
In 2025, the debt ratio of PHARMACIE MARTY (218.45) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
25.43%2025
2023
2024
2025
Q1: 33.69%
Méd: 53.88%
Q3: 72.26%
Watch-5 pts durante 3 años
In 2025, the financial autonomy of PHARMACIE MARTY (25.4%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Ratios de liquidez
The liquidity ratio (= Current assets / Current liabilities) stands at 118.54. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Ratio de liquidez (2025)
?
Ratio de liquidez
Definición
Capacidad para pagar las deudas a corto plazo con el activo circulante.
Fórmula
Activo circulante / Pasivo circulante
Interpretación
> 1.5 : Muy bueno 1-1.5 : Correcto < 1 : Risque de liquidité
118.541
Evolución de indicadores de liquidez PHARMACIE MARTY
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicador
2018
2019
2020
2021
2022
2023
2024
2025
Ratio de liquidez
146.57
157.31
196.141
130.073
181.619
145.238
172.753
118.541
Cobertura de intereses
None
None
None
None
None
None
None
None
Positionnement sectoriel
Liquidity ratio
118.542025
2023
2024
2025
Q1: 131.48
Méd: 182.6
Q3: 258.72
Watch-7 pts durante 3 años
In 2025, the liquidity ratio of PHARMACIE MARTY (118.54) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positionnement de PHARMACIE MARTY dans son secteur
Comparación con el sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Estimación de valoración
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE MARTY is estimated at
2 631 846 €
(range 1 785 983€ - 4 129 729€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1785k€2631k€4129k€
2 631 846 €Range: 1 785 983€ - 4 129 729€
NAF 5 année 2025
Valuation method used
Net Income Multiple
165 680 €
×
15.9x
=2 631 846 €
Range: 1 785 983€ - 4 129 730€
Only this financial indicator is available for this company.
Evolución de la valoración
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE MARTY with other companies in the same sector:
The revenue of PHARMACIE MARTY is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE MARTY profitable?
Yes, PHARMACIE MARTY generated a net profit of 166 k€ in 2025.
Where is the headquarters of PHARMACIE MARTY ?
The headquarters of PHARMACIE MARTY is located in ESPALION (12500), in the department Aveyron.
Where to find the tax return of PHARMACIE MARTY ?
The tax return of PHARMACIE MARTY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE MARTY operate?
PHARMACIE MARTY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Gire su teléfono en modo horizontal para ver el gráfico